Legend Biotech Corporation (LEGN)

Legend Biotech (LEGN) Stock Price & Analysis


LEGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$37.30 - $77.32
Previous Close$64.24
Average Volume (3M)542.21K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$786.03M
Total Debt (Recent Filing)$284.53M
Price to Earnings (P/E)-22.0
Mar 15, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.92
Shares Outstanding165,067,240
10 Day Avg. Volume428,352
30 Day Avg. Volume542,210
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)14.87
Price to Sales (P/S)90.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside43.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Legend Biotech Corporation’s price range in the past 12 months?
Legend Biotech Corporation lowest stock price was $37.30 and its highest was $77.32 in the past 12 months.
    What is Legend Biotech Corporation’s market cap?
    Currently, no data Available
    When is Legend Biotech Corporation’s upcoming earnings report date?
    Legend Biotech Corporation’s upcoming earnings report date is Mar 15, 2024 which is in 176 days.
      How were Legend Biotech Corporation’s earnings last quarter?
      Legend Biotech Corporation released its earnings results on Aug 15, 2023. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.361 by -$0.209.
        Is Legend Biotech Corporation overvalued?
        According to Wall Street analysts Legend Biotech Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Legend Biotech Corporation pay dividends?
          Legend Biotech Corporation does not currently pay dividends.
          What is Legend Biotech Corporation’s EPS estimate?
          Legend Biotech Corporation’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Legend Biotech Corporation have?
          Legend Biotech Corporation has 165,067,250 shares outstanding.
            What happened to Legend Biotech Corporation’s price movement after its last earnings report?
            Legend Biotech Corporation reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.361. Following the earnings report the stock price went down -4.833%.
              Which hedge fund is a major shareholder of Legend Biotech Corporation?
              Among the largest hedge funds holding Legend Biotech Corporation’s share is RA Capital Management. It holds Legend Biotech Corporation’s shares valued at 432M.


                Legend Biotech Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Legend Biotech Corporation

                Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Its other pipeline products include LB1910, LB1909, LB1903, and others. Geographically, the company generates a majority of its revenue from North America.


                Top 5 ETFs holding LEGN

                Market Value
                Smart Score
                Fidelity Nasdaq Composite Index ETF
                Fidelity New Millennium ETF
                T. Rowe Price Growth Stock ETF
                T. Rowe Price Growth ETF
                Up to five ETFs with an Outperform Smart Score that hold LEGN. The ETFs are listed according to market value of LEGN within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Kura Oncology
                Crispr Therapeutics AG
                Bluebird Bio

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis